Autolus Therapeutics (AUTL) Total Debt (2017 - 2019)

Autolus Therapeutics (AUTL) has 3 years of Total Debt data on file, last reported at $30000.0 in Q3 2019.

• Quarterly Total Debt fell 92.11% year-over-year to $30000.0 in Q3 2019, while the trailing twelve-month figure through Sep 2019 was $30000.0 (down 92.11% YoY) and the FY2019 annual result came in at $30000.0, down 92.11% from the prior year.
• Total Debt eased to $30000.0 in Q3 2019, from $121000.0 in the prior quarter.
• In the past five years, Total Debt ranged from a high of $763000.0 in Q3 2017 to a low of $30000.0 in Q3 2019.
• A 3-year average of $315800.0 and a median of $285000.0 in 2018 frame the typical range for Total Debt.
• Annual changes were most pronounced in 2018 — Total Debt plunged 50.2% — and 2019, when it tumbled 92.11%.
• Tracing AUTL's Total Debt over 3 years: stood at $763000.0 in 2017, then tumbled by 62.65% to $285000.0 in 2018, then tumbled by 89.47% to $30000.0 in 2019.
• The last three Total Debt figures came in at $30000.0 (Q3 2019), $121000.0 (Q2 2019), and $285000.0 (Q4 2018), per Business Quant data.